Thursday, 27 May 2010
AMRI cuts back in US
AMRI is closing its Rensselaer, NY, facility, with the loss of 50 jobs. A further 30 jobs will be lost at its other US facilities while the company plans to add 180 jobs in Asia as it invests $30m in its international facilities.
Albany Business Journal
Tuesday, 25 May 2010
Pfizer cuts eight manufacturing sites; cuts back at others
Pfizer plans to cease operations at eight plants in Ireland, Puerto Rico and the United States by late 2015 and reduce activities at six factories in those countries, plus Germany and Britain. The cuts will result in 6000 job losses.
Reuters
Consortium passes passes flu vax manufacturing test
A consortium led by Xcellerex has successfully demonstrated the production of purified swine flu H1 hemagglutinin (California strain) in 42 days starting from the amino acid sequence of the protein. The test results exceeded the goal for rate of production by at least 10 fold and exceeded all product quality specifications. The team, guided by BioPharm Services, combined Pfenex’s Pseudomonas fluorescens-based rapid strain engineering platform with Xcellerex’s microbial high speed process development and single-use manufacturing technologies and deltaDOT’s label free CE-based analytical technology.
In-Pharma Technologist
Thursday, 13 May 2010
Wednesday, 5 May 2010
American Peptide expands peptide production capacity
American Peptide has expanded its Vista, California cGMP peptide production facility. The large-scale facility expansion includes four new peptide purification suites. The company will also add two new synthesis suites and multi-kg lyophilisation capacity.
In-Pharma Technologist
